BR0209361A - Dissódio de pamidronato injetável - Google Patents
Dissódio de pamidronato injetávelInfo
- Publication number
- BR0209361A BR0209361A BR0209361-8A BR0209361A BR0209361A BR 0209361 A BR0209361 A BR 0209361A BR 0209361 A BR0209361 A BR 0209361A BR 0209361 A BR0209361 A BR 0209361A
- Authority
- BR
- Brazil
- Prior art keywords
- injectable
- pamidronate
- pamidronate disodium
- alkaline salt
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"DISSóDIO DE PAMIDRONATO INJETáVEL". A invenção inclui uma composição líquida embalada de um sal alcalino do pamidronato em um recipiente para o armazenamento vedado, que tenha uma superfície interna que não entre em reação com a composição de sal alcalino do pamidronato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28829301P | 2001-05-02 | 2001-05-02 | |
PCT/US2002/013801 WO2002087592A1 (en) | 2001-05-02 | 2002-05-01 | Injectable pamidronate disodium |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0209361A true BR0209361A (pt) | 2004-06-08 |
Family
ID=23106515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0209361-8A BR0209361A (pt) | 2001-05-02 | 2002-05-01 | Dissódio de pamidronato injetável |
Country Status (12)
Country | Link |
---|---|
US (1) | US6709674B2 (pt) |
EP (1) | EP1390044A4 (pt) |
BR (1) | BR0209361A (pt) |
CA (1) | CA2445584A1 (pt) |
CZ (1) | CZ20032951A3 (pt) |
EE (1) | EE200300477A (pt) |
HU (1) | HUP0400087A3 (pt) |
MX (1) | MXPA03009890A (pt) |
PL (1) | PL363537A1 (pt) |
RU (1) | RU2003134700A (pt) |
SK (1) | SK13522003A3 (pt) |
WO (1) | WO2002087592A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2406446A1 (en) * | 2000-09-18 | 2002-03-21 | Gregory Paul Handreck | Diphosphonate solutions |
CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
MY141763A (en) * | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
US20060063720A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Oxaliplatin solution concentrate |
US20060063833A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Ready-to-use oxaliplatin solutions |
WO2006100687A1 (en) * | 2005-03-24 | 2006-09-28 | Dabur Pharma Ltd. | Disodium pamidronate aqueous formulation |
WO2011163389A2 (en) * | 2010-06-25 | 2011-12-29 | The Trustees Of Columbia University In The City Of New York | Method for inducing fat loss in mammals |
CN103040766B (zh) * | 2013-01-10 | 2015-09-02 | 罗诚 | 一种含有帕米磷酸二钠化合物的药物组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 Düsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
US4639338A (en) | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
US6160165A (en) | 1998-12-10 | 2000-12-12 | Aesgen, Inc. | Method for preparation of disodium pamidronate |
ATE238315T1 (de) * | 1998-12-10 | 2003-05-15 | Aesgen Inc | Verfahren zur herstellung von dinatriumpamidronat |
AUPR018900A0 (en) | 2000-09-18 | 2000-10-12 | Fh Faulding Pty Limited | Pamidronate solution |
-
2002
- 2002-05-01 BR BR0209361-8A patent/BR0209361A/pt not_active IP Right Cessation
- 2002-05-01 RU RU2003134700/15A patent/RU2003134700A/ru not_active Application Discontinuation
- 2002-05-01 EP EP02726828A patent/EP1390044A4/en not_active Withdrawn
- 2002-05-01 CA CA002445584A patent/CA2445584A1/en not_active Abandoned
- 2002-05-01 EE EEP200300477A patent/EE200300477A/xx unknown
- 2002-05-01 HU HU0400087A patent/HUP0400087A3/hu unknown
- 2002-05-01 CZ CZ20032951A patent/CZ20032951A3/cs unknown
- 2002-05-01 MX MXPA03009890A patent/MXPA03009890A/es active IP Right Grant
- 2002-05-01 SK SK1352-2003A patent/SK13522003A3/sk not_active Application Discontinuation
- 2002-05-01 US US10/137,205 patent/US6709674B2/en not_active Expired - Fee Related
- 2002-05-01 PL PL02363537A patent/PL363537A1/xx not_active Application Discontinuation
- 2002-05-01 WO PCT/US2002/013801 patent/WO2002087592A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200300477A (et) | 2003-12-15 |
CZ20032951A3 (cs) | 2004-02-18 |
EP1390044A1 (en) | 2004-02-25 |
WO2002087592A1 (en) | 2002-11-07 |
RU2003134700A (ru) | 2005-03-20 |
HUP0400087A2 (hu) | 2004-04-28 |
SK13522003A3 (sk) | 2004-04-06 |
PL363537A1 (en) | 2004-11-29 |
EP1390044A4 (en) | 2005-03-23 |
US6709674B2 (en) | 2004-03-23 |
MXPA03009890A (es) | 2004-02-17 |
HUP0400087A3 (en) | 2007-05-29 |
CA2445584A1 (en) | 2002-11-07 |
US20030069211A1 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE424117T1 (de) | Calciumhaltiger kaugummi mit mittiger füllung | |
WO2005089954A3 (en) | Unit dose delivery system for two-component composition | |
AR011714A1 (es) | Conjunto de envasado y de aplicacion de un producto liquido | |
ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
ES2166137T3 (es) | Embalaje dotado de un cupon y procedimiento de obtencion de dicho embalaje. | |
BR0208060A (pt) | Bolsa flexìvel com múltiplos compartimentos | |
ES2193578T3 (es) | Complejos de calcio para el enriquecimiento de alimentos. | |
MX171722B (es) | Recipiente distribuidor de substancia viscosa | |
AR034736A1 (es) | Sistema de emanacion de liquido a base de mecha | |
AR032705A1 (es) | Recipiente flexible que tiene pico resellable formado integralmente | |
DE60322098D1 (de) | Behälteranordnungssystem mit mehreren fächern | |
BR0209361A (pt) | Dissódio de pamidronato injetável | |
BR0116136B1 (pt) | embalagem comercial que compreende uma composição de branqueamento junto com as instruções para seu uso. | |
AR029254A1 (es) | Un sistema de envase y un cierre que comprende dicho envase | |
MXPA03008794A (es) | Mejoras en o relacionadas con dispositivos refrescantes de aire. | |
BR9905339A (pt) | Recipiente com elemento de retenção | |
DE60003943D1 (de) | Trimegestone enthaltende pharmazeutische zusammensetzungen | |
DE60306137D1 (de) | Verpackung für zigaretten | |
AR038215A1 (es) | Raticida envasado | |
AR040015A1 (es) | Miniesferas de alumbre | |
UY27932A1 (es) | Tapa y recipiente contenedor de productos | |
CO5580729A2 (es) | Composiciones nutricionales que comprenden cistationina | |
BRPI0504830A (pt) | sistema de trava para refil, embalagem que compreende o dito sistema de trava e refil | |
SV2006002222A (es) | Desoxidacion de polvos de metales rectificadores ref. sta 00233-sv | |
BRPI0408195A (pt) | embalagens solúveis em água contendo composições lìquidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 7A,8A E 9A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |